Skip to main content
NANOCO GROUP PLC logo

NANOCO GROUP PLC — Investor Relations & Filings

Ticker · NANO ISIN · GB00B01JLR99 LEI · 213800HOSJEZO1KOCV33 IL Manufacturing
Open in API
Filings indexed 962 across all filing types
Latest filing 2024-03-11 Regulatory Filings
Country GB United Kingdom
Listing IL NANO

About NANOCO GROUP PLC

https://www.nanocotechnologies.com/

Nanoco Group PLC is a nanotechnology company specializing in the research, development, manufacturing, and licensing of heavy-metal-free nanomaterials. The company is a world leader in patented cadmium-free quantum dots (CFQDs®), which are semiconductor nanoparticles whose optical and electronic properties can be precisely tuned for specific customer requirements. This technology platform enables a wide range of commercial applications. Key markets include advanced displays for consumer electronics and sensing applications in the Near-Infrared (NIR) and Short-Wave Infrared (SWIR) spectrums for sectors such as mobile devices, automotive, healthcare, and security.

Recent filings

Filing Released Lang Actions
Proposed return of up to £33.0 million
Regulatory Filings Classification · 98% confidence The document announces a 'Proposed return of up to £33.0 million to shareholders' via a 'Tender Offer' and a 'Share Buyback Programme'. It explicitly mentions that a 'Circular setting out the details' will be posted and that a 'general meeting of the Company is to be held... to seek the approval of Shareholders to the proposed Return of Value.' The text also details the mechanics of the Tender Offer and mentions that full details are included in the Circular to be published later today. Since the document is an announcement detailing a corporate action (return of capital/share repurchase) that requires shareholder approval and references a forthcoming Circular, it strongly suggests a filing related to shareholder voting or capital structure changes. The key elements are the Tender Offer (a form of share repurchase/capital change) and the required shareholder approval via a General Meeting. This aligns best with 'Transaction in Own Shares' (POS) due to the explicit Tender Offer/Buyback, or potentially 'Capital/Financing Update' (CAP). However, the core mechanism described is the repurchase of shares, which is the definition of POS. Furthermore, the document is an RNS announcement (RNS Number : 2467G) detailing a significant corporate action that requires shareholder approval, which often precedes or accompanies a Proxy Statement (PSI) or is itself a major regulatory disclosure. Given the focus on the Tender Offer (share repurchase), POS is the most specific fit for the action being taken. It is not the proxy statement itself (PSI) nor the final voting results (DVA).
2024-03-11 English
Half Year Trading Update
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content is titled "Half Year Trading Update" for the six months ended 31 January 2024, which is a pre-release update ahead of the full results announcement on March 27, 2024. This type of preliminary financial update, often containing key operational and financial highlights before the formal report, aligns best with an Earnings Release (ER) or potentially an Interim Report (IR). However, since it is explicitly a 'Trading Update' providing highlights and performance in line with expectations, it functions as an initial announcement of results, fitting the definition of an Earnings Release (ER). It is not the comprehensive Interim Report (IR) itself, nor is it a general regulatory filing (RNS) as it has a specific financial reporting purpose.
2024-02-08 English
Director Declaration
Board/Management Information Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS Number : 3641C' and 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces a change in a Non-Executive Director's board appointment at another company, which is a specific type of corporate disclosure. While it relates to director information, the primary context is the regulatory dissemination mechanism (RNS) for timely, non-standard announcements. Since the announcement is a specific corporate event disclosure (Director Declaration) disseminated via the RNS system, and it doesn't fit perfectly into MANG (which usually covers internal changes like resignation/appointment to *this* company's board) or DIRS (insider trading), the most appropriate general category for a timely, regulatory news service announcement that isn't a core financial report (10-K, IR, ER) is the general Regulatory Filings category (RNS). However, upon reviewing the definitions, the content is a 'Director Declaration' regarding a directorship change, which is a specific type of insider/governance disclosure. Given the options, 'Board/Management Information' (MANG) covers changes in the board, and this is a notification about a director's external appointment, which is often covered under governance/director updates. Since the document explicitly cites UK Listing Rules 9.6.14, it is a formal regulatory disclosure. If we must choose the most specific fit among the options, MANG covers board changes. However, RNS is the mechanism used for dissemination. Since the content is a specific notification about a director's external appointment, and it is not a Director's Dealing (DIRS), MANG is a strong candidate for the *subject matter*. But because it is presented as a standard RNS announcement, and RNS is the fallback for miscellaneous regulatory filings, I will check if DIRS or MANG is better. It is not a transaction (DIRS). It is a notification about a director's status change, which falls under Board/Management Information (MANG). I will classify it as MANG as the subject matter is a director change, despite the RNS wrapper.
2024-02-07 English
Receipt of Final Litigation Proceeds
Earnings Release Classification · 99% confidence The document is identified by the RNS Number header and the explicit mention of 'RNS Number : 6851A' and 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a regulatory announcement disseminated through the London Stock Exchange's Regulatory News Service. The content discusses the 'Receipt of Final Litigation Proceeds' and subsequent 'Proposals for Return of Capital to follow'. While it contains significant financial updates (receipt of $71.75m, plans for capital return), it is structured as a formal announcement intended for immediate public disclosure under market abuse regulations ('THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION...'). It is not a full Annual Report (10-K), an Interim Report (IR), or a detailed Earnings Release (ER). It is a specific, material corporate event announcement. Given the structure (RNS format, immediate release, inside information disclosure) and the nature of the content (announcing a major cash receipt and upcoming capital return proposals), the most appropriate classification is the general regulatory announcement category, RNS, as it serves as the primary vehicle for such disclosures to the market, especially when the specific content (litigation proceeds/capital return plan) doesn't perfectly align with other specific codes like CAP (Capital/Financing Update) or LTR (Legal Proceedings Report), although it touches upon those themes. Since it is a standard RNS release, RNS is the best fit, acting as the primary regulatory disclosure channel. FY 2024
2024-01-24 English
Notification Of Transactions By PDMR
Director's Dealing Classification · 100% confidence The document is titled "NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY" and details the grant of stock options to executive directors (CEO, CTO, CFO) under incentive plans (LTIP and DBP). It explicitly mentions compliance with UK Market Abuse Regulation and uses the RNS Number format, indicating a regulatory announcement. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS).
2024-01-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'DIRECTOR/PDMR SHAREHOLDING' and details transactions (purchases) of ordinary shares by the Non-Executive Chairman, CEO's PCA, and CFO of Nanoco Group PLC. This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing. The presence of the RNS Number and the reference to EU Market Abuse Regulation confirms it is a regulatory disclosure related to insider transactions.
2024-01-16 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.